Correlation Between Mereo BioPharma and SSgA SPDR

Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and SSgA SPDR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and SSgA SPDR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mereo BioPharma Group and SSgA SPDR ETFs, you can compare the effects of market volatilities on Mereo BioPharma and SSgA SPDR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of SSgA SPDR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and SSgA SPDR.

Diversification Opportunities for Mereo BioPharma and SSgA SPDR

-0.73

Correlation Coefficient

Mereo BioPharma  SSgA SPDR

Pay attention - limited upside

The 3 months correlation between Mereo and SSgA is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and SSgA SPDR ETFs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SSgA SPDR ETFs and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with SSgA SPDR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SSgA SPDR ETFs has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and SSgA SPDR go up and down completely randomly.

Pair Corralation between Mereo BioPharma and SSgA SPDR

Assuming the 90 days trading horizon Mereo BioPharma Group is expected to generate 13.33 times more return on investment than SSgA SPDR. However, Mereo BioPharma is 13.33 times more volatile than SSgA SPDR ETFs. It trades about 0.04 of its potential returns per unit of risk. SSgA SPDR ETFs is currently generating about -0.06 per unit of risk. If you would invest  355.00  in Mereo BioPharma Group on September 30, 2024 and sell it today you would earn a total of  5.00  from holding Mereo BioPharma Group or generate 1.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.24%
Values	Daily Returns

Mereo BioPharma Group  vs.  SSgA SPDR ETFs

Mereo BioPharma Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Mereo BioPharma is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

SSgA SPDR ETFs

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in SSgA SPDR ETFs are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, SSgA SPDR may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Mereo BioPharma and SSgA SPDR

The main advantage of trading using opposite Mereo BioPharma and SSgA SPDR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, SSgA SPDR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SSgA SPDR will offset losses from the drop in SSgA SPDR's long position.

The idea behind Mereo BioPharma Group and SSgA SPDR ETFs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.